• $43,451.00
    Market Cap
  • 9,900.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
29,835
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
Total Operating Expenses
78.1M
+198,391.90%
39,327
N/A
Operating Profit
-78.1M
+198,391.90%
-39,327
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
Total Nonoperating Income and Expense
-1,862
-100.00%
-101.0M
N/A
Income before Taxes
-78.1M
+198,391.90%
-39,327
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-78.1M
-22.72%
-101.0M
N/A
Net Income from Continuing Operations Applicable to Common
-78.1M
-22.72%
-101.0M
N/A
Basic EPS and Net Income
-0.26
-25.71%
-0.35
N/A
Diluted EPS and Net Income
-0.26
-25.71%
-0.35
N/A
Basic Weighted Average Shares
305.4M
+7.19%
284.9M
N/A
Diluted Weighted Average Shares
305.4M
+7.19%
284.9M
N/A
Balance Sheet
Cash and Cash Equivalents
131
N/A
0
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
131
N/A
0
N/A
Total Current Assets
131
N/A
0
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
Total Assets
5,131
N/A
0
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
97,443
+824.86%
10,536
N/A
Total Current Liabilities
99,305
+172.79%
36,404
N/A
Total Long-Term Debt
0
-100.00%
23,000
N/A
Total Long-Term Liabilities
0
N/A
N/A
N/A
Total Liabilities
99,305
+67.17%
59,404
N/A
Retained Earnings
-179.4M
+77.02%
-101.4M
N/A
Total Stockholders Equity
-94,174
+58.53%
-59,404
N/A
Total Shares Outstanding
434.2M
+77.63%
244.4M
N/A
Cash Flow
Cash from Operating Activities
-86,776
+277.29%
-23,000
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
86,907
+277.86%
23,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-3,042,789.71%
N/A
N/A
N/A
Return on Equity
101,658.79%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
0.001
N/A
N/A
N/A
Cash Ratio
0.001
N/A
N/A
N/A
Debt-to-Equity Ratio
-1.03
N/A
N/A
N/A
Debt-to-Assets Ratio
18.99
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow